Mario Lobigs
St Lucia
QLD, Australia
QLD, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Partial dysfunction of STAT1 profoundly reduces host resistance to flaviviral infection.
Journal: Virology
Published: December 02, 2016
Proteolytic cleavage analysis at the Murray Valley encephalitis virus NS1-2A junction.
Journal: Virology journal
Published: February 25, 2015
Mutagenesis analysis of T380R mutation in the envelope protein of yellow fever virus.
Journal: Virology journal
Published: February 12, 2014
Internal ribosome entry site-based attenuation of a flavivirus candidate vaccine and evaluation of the effect of beta interferon coexpression on vaccine properties.
Journal: Journal of virology
Published: December 06, 2013
JE-ADVAX vaccine protection against Japanese encephalitis virus mediated by memory B cells in the absence of CD8(+) T cells and pre-exposure neutralizing antibody.
Journal: Journal of virology
Published: February 08, 2013
Cytolytic effector pathways and IFN-γ help protect against Japanese encephalitis.
Journal: European journal of immunology
Published: November 14, 2012
Identification of residues in West Nile virus pre-membrane protein that influence viral particle secretion and virulence.
Journal: The Journal of general virology
Published: July 06, 2012
The chemokine receptor CCR5, a therapeutic target for HIV/AIDS antagonists, is critical for recovery in a mouse model of Japanese encephalitis.
Journal: PloS one
Published: May 04, 2012
Feasibility of cross-protective vaccination against flaviviruses of the Japanese encephalitis serocomplex.
Journal: Expert review of vaccines
Published: February 08, 2012
An inactivated Vero cell-grown Japanese encephalitis vaccine formulated with Advax, a novel inulin-based adjuvant, induces protective neutralizing antibody against homologous and heterologous flaviviruses.
Journal: The Journal of general virology
Published: February 05, 2010
Last Updated: 09/26/2026